Credit Suisse’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-266,909
| Closed | -$16M | – | 3609 |
|
|
2019
Q4 | $16M | Buy |
266,909
+203,671
| +322% | +$12.2M | 0.01% | 873 |
|
|
2019
Q3 | $1.78M | Buy |
63,238
+3,350
| +6% | +$94.1K | ﹤0.01% | 2004 |
|
|
2019
Q2 | $2.27M | Buy |
59,888
+1,111
| +2% | +$42.1K | ﹤0.01% | 1864 |
|
|
2019
Q1 | $2.29M | Buy |
58,777
+8,310
| +16% | +$324K | ﹤0.01% | 1814 |
|
|
2018
Q4 | $1.08M | Buy |
50,467
+28,614
| +131% | +$610K | ﹤0.01% | 2238 |
|
|
2018
Q3 | $865K | Sell |
21,853
-2,088
| -9% | -$82.6K | ﹤0.01% | 2511 |
|
|
2018
Q2 | $914K | Sell |
23,941
-10,592
| -31% | -$404K | ﹤0.01% | 2644 |
|
|
2018
Q1 | $1.04M | Buy |
34,533
+19,820
| +135% | +$595K | ﹤0.01% | 2539 |
|
|
2017
Q4 | $459K | Buy |
14,713
+2,523
| +21% | +$78.7K | ﹤0.01% | 2990 |
|
|
2017
Q3 | $341K | Buy |
+12,190
| New | +$341K | ﹤0.01% | 3201 |
|